MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/17.01.25 Share Price

Warrant

DE000MB1X1V3

Market Closed - Börse Stuttgart 12:18:59 15/06/2024 am IST
0.103 EUR +0.98% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/17.01.25
Current month-24.82%
1 month-13.45%
Date Price Change
14/24/14 0.103 +0.98%
13/24/13 0.102 +5.15%
12/24/12 0.097 +3.19%
11/24/11 0.094 -1.05%
10/24/10 0.095 -2.06%

Delayed Quote Börse Stuttgart

Last update June 15, 2024 at 12:18 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB1X1V
ISINDE000MB1X1V3
Date issued 30/12/2022
Strike 100 $
Maturity 17/01/2025 (215 Days)
Parity 10 : 1
Emission price 1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.08
Lowest since issue 0.075
Spread 0.004
Spread %3.81%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
142.7 USD
Spread / Average Target
+10.20%
Consensus